Publications Systematic review with meta-analysis: prevalence, risk factors and costs of aminosalicylate use in Crohn’s disease Citation Ma C, Dutton SJ, Cipriano LE, Singh S, Parker CE, Nguyen TM, Guizzetti L, Gregor JC, Chande N, Hindryckx P, Feagan BG, Jairath V. Systematic review with meta-analysis: prevalence, risk factors and costs of aminosalicylate use in Crohn's disease. Aliment Pharmacol Ther. 2018 Jul;48(2):114-126. doi: 10.1111/apt.14821. Epub 2018 May 30. PMID: 29851091. Abstract Background: Aminosalicylates are the most frequently prescribed drugs for patients with Crohn’s disease (CD), yet evidence to support their efficacy as induction or maintenance therapy is controversial. Tags Adrenal Cortex Hormones, Adverse Effects, Biological Products, Crohn's Disease, Drug Therapy, Epidemiology, Immunosuppressive Agents, Mesalamine, therapeutic use Read More
